Transaction DateRecipientSharesTypePriceValue
6th October 2020Martin E Franklin500,000Open or private purchase$11.50$5,750,000.00
1st October 2020Ian G H Ashken10,000Exercise of derivative$0.00
1st October 2020E Stanley Oneal1,433Grant/award etc.$18.83$26,983.39
15th September 2020Christopher T. Fraser1,427Open or private purchase$11.48$16,381.96
15th September 2020Christopher T. Fraser6,573Open or private purchase$11.49$75,523.77
1st September 2020E Stanley Oneal262Grant/award etc.$0.00
1st September 2020Christopher T. Fraser100,000Open or private purchase$1.63$163,000.00
27th August 2020Patricia Mount1,000Bona fide gift$0.00
14th July 2020Scot Benson2,879Payment by withholding$11.05$31,812.95
14th July 2020Scot Benson58,789Exercise of derivative$0.00
Platform Specialty Products Corp
Platform Specialty Products Corp logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 6/10.

The company provides technology chemical products and technical services. It is based in the United States and has offices in London and New York. The company was founded in 1903 and has operations across the globe.

Ticker: PAH
Sector: Process Industries
Industry: Chemicals: Specialty
SEC Central Index Key (CIK): 1590714
Employees: 7850
Exchange: New York Stock Exchange
Auditor Opinion:

Disclosure Language changes
Red Flags
Cash at Carrying Value: $237 M (24%)
Inventory, Net: $211 M (0%)
Other Assets, Current: $51 M (1%)
Assets, Current: $839 M (0%)
Property, Plant and Equipment, Net: $254 M (0%)
Other Assets, Noncurrent: $116 M (21%)
Assets: $4 B (-2%)
Accounts Payable, Current: $80 M (-17%)
Liabilities, Current: $246 M (-16%)
Other Liabilities, Noncurrent: $139 M (9%)
Liabilities: $2 B (-1%)
Common Stock, Value, Issued: $3 M (0%)
Common Stock, Shares, Issued: $261 (1%)
Retained Earnings (Accumulated Deficit): $2 B (0%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $324 M (15%)
Treasury Stock, Value: $1 Th (44%)
Treasury Stock, Shares: $122 (46%)
Stockholders' Equity (Parent): $2 B (-2%)
Liabilities and Equity: $4 B (-2%)
Revenue: $387 M (0%)
Cost of Revenue: $224 M (0%)
Gross Margin: $162 M (0%)
Research and Development: $10 M (0%)
Restructuring Charges: $3 M (-23%)
Operating Income/Loss: $40 M (0%)
Other Income, net: $31 M (0%)
Provision for income taxes: $6 M (0%)
EPS (basic): $0.01 (-75%)
EPS (diluted): $0.01 (-75%)